158 related articles for article (PubMed ID: 26193425)
1. Sponsor-Imposed Publication Restrictions Disclosed on ClinicalTrials.gov.
Stretton S; Lew RA; Ely JA; Snape MJ; Carey LC; Haley C; Woolley MJ; Woolley KL
Account Res; 2016; 23(2):67-78. PubMed ID: 26193425
[TBL] [Abstract][Full Text] [Related]
2. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
[TBL] [Abstract][Full Text] [Related]
3. [Constraints on publication rights in industry-initiated clinical trials--secondary publication].
Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372
[TBL] [Abstract][Full Text] [Related]
4. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
5. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
6. Comparison of arthroplasty trial publications after registration in ClinicalTrials.gov.
Smith HN; Bhandari M; Mahomed NN; Jan M; Gandhi R
J Arthroplasty; 2012 Aug; 27(7):1283-8. PubMed ID: 22226609
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
Gresham G; Meinert JL; Gresham AG; Meinert CL
JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
9. [Registration of clinical trials: a statement from the International Committee of Medical Journal Editors].
DeAngelis C; Drazen JM; Frizelle FA; Haug C; Hoey J; Horton R; Kotzin S; Laine C; Marusic A; Overbeke AJ; Schroeder TV; Sox HC; van der Weyden MB;
Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1870-1. PubMed ID: 15497781
[TBL] [Abstract][Full Text] [Related]
10. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
[TBL] [Abstract][Full Text] [Related]
11. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
12. Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.
Hopkins AM; Rowland A; Sorich MJ
BMC Med; 2018 Sep; 16(1):165. PubMed ID: 30261889
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014.
Deane BR; Porkess S
Curr Med Res Opin; 2018 Jul; 34(7):1239-1243. PubMed ID: 29219621
[TBL] [Abstract][Full Text] [Related]
14. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
16. Publication Rates of Registered Corneal Trials on ClinicalTrials.gov.
Cehelyk EK; Crespo MA; Syed ZA
Cornea; 2024 Mar; 43(3):356-359. PubMed ID: 37404122
[TBL] [Abstract][Full Text] [Related]
17. Editorial policies of pediatric journals: survey of instructions for authors.
Meerpohl JJ; Wolff RF; Niemeyer CM; Antes G; von Elm E
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):268-72. PubMed ID: 20194261
[TBL] [Abstract][Full Text] [Related]
18. Thirty years of disclosure of conflict of interest in surgery journals.
Probst P; Hüttner FJ; Klaiber U; Diener MK; Büchler MW; Knebel P
Surgery; 2015 Apr; 157(4):627-33. PubMed ID: 25704418
[TBL] [Abstract][Full Text] [Related]
19. Clinical Trial Outcomes in Urology: Assessing Early Discontinuation, Results Reporting and Publication in ClinicalTrials.Gov Registrations 2007-2019.
Magnani CJ; Steinberg JR; Harmange CI; Zhang X; Driscoll C; Bell A; Larson J; You JG; Weeks BT; Hernandez-Boussard T; Turner BE; Brooks JD
J Urol; 2021 Apr; 205(4):1159-1168. PubMed ID: 33079618
[TBL] [Abstract][Full Text] [Related]
20. Transparency and credibility of industry-sponsored clinical trial publications: a survey of journal editors.
Mooney LA; Fay L; DeCastro B; Zanki TA; Mansi B
Curr Med Res Opin; 2019 Jul; 35(7):1221-1230. PubMed ID: 30648455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
